Table 2.

Quasispecies complexity (Sn) between the patients with coexisting HBsAg and anti-HBs and controls.

Region of variation (level)	Experimental group (mean ± SE) (n = 6)	Control group (mean ± SE) (n = 6)	P value
Full length (nt)	0.865 ± 0.0647	0.8334 ± 0.0445	0.695
PreS/S
Large HBsAg (nt)	0.8488 ± 0.0615	0.8241 ± 0.057	0.774
Large HBsAg (aa)	0.7889 ± 0.0646	0.6929 ± 0.0593	0.300
Middle HBsAg (nt)	0.7819 ± 0.0562	0.7673 ± 0.0499	0.850
Middle HBsAg (aa)	0.7434 ± 0.051	0.5897 ± 0.0773	0.128
HBsAg (nt)	0.7484 ± 0.0548	0.6535 ± 0.0691	0.307
HBsAg (aa)	0.6756 ± 0.0646	0.517 ± 0.0942	0.195
X
HBxAg (nt)	0.6766 ± 0.0683	0.6321 ± 0.0742	0.668
HBxAg (aa)	0.5322 ± 0.0871	0.5177 ± 0.0423	0.884
CP/C
HBcAg (nt)	0.6154 ± 0.0724	0.6715 ± 0.0519	0.543
HBcAg (aa)	0.452 ± 0.0627	0.5362 ± 0.0904	0.462
Core promoter (nt)	0.5367 ± 0.0297	0.5113 ± 0.0443	0.645
procore (nt)	0.6758 ± 0.0555	0.6997 ± 0.065	0.785
P
Polymerase (nt)	0.865 ± 0.0647	0.8055 ± 0.0521	0.490
Polymerase (aa)	0.8381 ± 0.0652	0.8052 ± 0.0405	0.677
RT region (nt)	0.7889 ± 0.0613	0.7562 ± 0.0496	0.687
RT region (aa)	0.7631 ± 0.0503	0.6989 ± 0.0601	0.432